MENU
+Compare
EVGN
Stock ticker: NASDAQ
AS OF
Oct 7, 04:58 PM (EDT)
Price
$1.33
Change
+$0.08 (+6.40%)
Capitalization
10.39M

EVGN Evogene Ltd. Forecast, Technical & Fundamental Analysis

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications... Show more

Industry: #Biotechnology
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EVGN with price predictions
Oct 06, 2025

EVGN's RSI Oscillator recovers from oversold territory

The RSI Oscillator for EVGN moved out of oversold territory on September 26, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where EVGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 06, 2025. You may want to consider a long position or call options on EVGN as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EVGN just turned positive on October 06, 2025. Looking at past instances where EVGN's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

EVGN moved above its 50-day moving average on October 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EVGN advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EVGN broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EVGN entered a downward trend on October 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.834) is normal, around the industry mean (23.464). P/E Ratio (0.304) is within average values for comparable stocks, (54.589). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.244). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.881) is also within normal values, averaging (345.477).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EVGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVGN is expected to report earnings to fall 50.00% to -42 cents per share on November 12

Evogene Ltd. EVGN Stock Earnings Reports
Q3'25
Est.
$-0.43
Q2'25
Missed
by $0.24
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.66
Q3'24
Missed
by $0.30
The last earnings report on August 19 showed earnings per share of -85 cents, missing the estimate of -61 cents. With 66.78K shares outstanding, the current market capitalization sits at 10.39M.
A.I. Advisor
published General Information

General Information

a developer of plant traits for the agriculture and biofuel industries

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13 Gad Feinstein Street
Phone
+972 89311900
Employees
142
Web
https://www.evogene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HIFS293.6314.22
+5.09%
Hingham Institution for Savings
NEXM5.740.18
+3.24%
Nexmetals Mining Corp
LCFY7.230.01
+0.14%
Locafy Limited
OGN10.84-0.17
-1.54%
Organon & Co
ZBH98.83-1.95
-1.93%
Zimmer Biomet Holdings

EVGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EVGN has been loosely correlated with CARM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EVGN jumps, then CARM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
+8.70%
CARM - EVGN
58%
Loosely correlated
-1.88%
INSM - EVGN
35%
Loosely correlated
+0.71%
AXON - EVGN
30%
Poorly correlated
+0.85%
ARRY - EVGN
28%
Poorly correlated
-1.54%
TERN - EVGN
28%
Poorly correlated
+2.43%
More